Big Breakthrough in Infant Care: First Approved Malaria Drug for Newborns – Coartem Baby by Novartis

In a major step forward for infant healthcare and malaria treatment, Novartis has received approval from Swissmedic for its new medicine Coartem Baby (also known as Riamet Baby in some countries). This is the first-ever malaria treatment officially approved for newborns and young infants, especially those weighing less than 4.5 kilograms. This breakthrough offers new […]
Read more

Making Medicines Accessible: Govt Panel Proposes Braille Cards & Voice-Enabled QR Codes for the Visually Impaired

In a significant step toward accessible healthcare in India, the Drugs Consultative Committee (DCC) has proposed new measures to help visually impaired individuals identify and use medicines more safely and independently. What’s the Proposal About? At the 66th DCC meeting held on June 17, 2025, the committee recommended innovative packaging changes for medicines. These include: […]
Read more

A Light in the Dark: New Drug Helps Surgeons See Nerves, Making Surgeries Safer and Faster

A major innovation in surgery may soon transform how delicate operations are performed. Researchers at the University of New Mexico (UNM), in collaboration with scientists from the University of California, San Diego (UCSD), have developed a groundbreaking drug called Bevonescein—a first-of-its-kind imaging agent that makes nerve tissue glow under special light, helping surgeons avoid damaging […]
Read more

🚨 WHO Issues Global Safety Alert on Semaglutide: Vision Loss Risk Identified

The World Health Organization (WHO) has issued an important global safety alert regarding the use of semaglutide-containing medicines, warning about a rare but serious side effect that could lead to irreversible vision loss. This update is highly relevant for healthcare professionals, endocrinologists, diabetologists, and all providers managing patients on semaglutide-based treatments such as Ozempic®, Rybelsus®, […]
Read more